| Literature DB >> 33841963 |
Jun Zhong1, Jian Gao2, Jing-Chao Luo3, Ji-Li Zheng1, Guo-Wei Tu3, Yan Xue1.
Abstract
BACKGROUND: Patients readmitted to the intensive care unit (ICU) after cardiac surgery have a high mortality rate. The relationship between renal function and in-hospital mortality in readmitted patients has not been well demonstrated.Entities:
Keywords: Readmission; cardiac surgery; intensive care unit (ICU); mortality; serum creatinine (SCR)
Year: 2021 PMID: 33841963 PMCID: PMC8024843 DOI: 10.21037/jtd-20-3205
Source DB: PubMed Journal: J Thorac Dis ISSN: 2072-1439 Impact factor: 2.895
Patient characteristics by survival status (n=184)
| Variables | Alive (n=154) | Dead (n=30) | P value |
|---|---|---|---|
| Age (years), mean ± SD | 62.21±10.73 | 60.47±12.50 | 0.428 |
| Sex (male), n (%) | 86 (55.84) | 22 (73.33) | 0.075 |
| BMI (kg/m2), mean ± SD | 23.69±3.54 | 22.95±3.89 | 0.301 |
| Hypertension, n (%) | 82 (53.25) | 12 (40.00) | 0.184 |
| Diabetes, n (%) | 25 (16.23) | 8 (26.67) | 0.173 |
| CKD, n (%) | 11 (7.14) | 2 (6.67) | 1.000 |
| History of cardiac surgery, n (%) | 28 (18.18) | 7 (23.33) | 0.511 |
| NYHA functional classification, n (%) | 0.945 | ||
| Class I | 11 (7.14) | 6 (20.00) | |
| Class II | 25 (16.23) | 2 (6.67) | |
| Class III | 100 (64.94) | 16 (53.33) | |
| Class IV | 18 (11.69) | 6 (20.00) | |
| Type of surgery, n (%) | 0.034 | ||
| CABG only | 17 (11.04) | 1 (3.33) | |
| Valve surgery | 86 (55.84) | 12 (40.00) | |
| Valve surgery with CABG | 5 (3.25) | 3 (10.00) | |
| Aortic surgery | 21 (13.64) | 9 (30.00) | |
| CHD surgery | 9 (5.84) | 0 (0.00) | |
| Others | 16 (10.39) | 5 (16.67) | |
| Surgery category: aortic, n (%) | 21 (13.64) | 9 (30.00) | 0.026 |
| Euro Score, median (range) | 4.50 (3.00–6.00) | 4.50 (3.00–7.50) | 0.404 |
| Preoperative LVEF (%), mean ± SD | 59.69±10.13 | 57.72±10.44 | 0.343 |
| Preoperative SCR (μmol/L), mean ± SD | 88.05±38.23 | 101.73±64.01 | 0.116 |
| Preoperative eGFR (mL/min), mean ± SD | 76.90±21.14 | 72.60±22.79 | 0.316 |
| APACHE II, median (range) | 10.00 (7.00–13.00) | 15.00 (11.00–23.00) | <0.001 |
| Postoperative LVEF (%), mean ± SD | 52.54±11.39 | 50.25±14.62 | 0.352 |
| Readmission SCR (μmol/L), mean ± SD | 114.11±74.84 | 230.60±112.07 | <0.001 |
| Readmission eGFR (mL/min), mean ± SD | 68.57±29.42 | 35.23±27.12 | <0.001 |
| ∆SCR (μmol/L), mean ± SD | 26.06±60.74 | 128.87±106.52 | <0.001 |
| ∆eGFR (mL/min), mean ± SD | −7.30±26.73 | −34.73±32.46 | <0.001 |
| Blood glucose (mg/mL), median (range) | 172.00 (140.50–202.50) | 148.00 (99.50–213.50) | 0.136 |
| Lactic acid (mmol/L), median (range) | 1.70 (1.20–2.50) | 4.80 (2.10–14.00) | <0.001 |
| Haemoglobin (g/L), mean ± SD | 94.97±20.42 | 94.13±18.30 | 0.834 |
| Platelet (×109), mean ± SD | 171.82±82.30 | 173.70±118.08 | 0.934 |
| WBC (×109), mean ± SD | 12.79±5.58 | 13.77±5.82 | 0.380 |
| AST (U/L), median (range) | 27.50 (15.00–61.25) | 58.00 (21.75–235.00) | 0.018 |
| ALT (U/L), median (range) | 33.00 (22.00–63.75) | 55.00 (24.75–160.50) | 0.014 |
| Infection before readmission, n (%) | 25 (16.23) | 16 (53.33) | <0.001 |
| More than one ICU readmission, n (%) | 14 (9.15) | 4 (13.33) | 0.704 |
| Length of stay in the general ward before readmission (days), median (range) | 2.00 (1.00–5.00) | 5.50 (1.75–11.25) | 0.011 |
| Length of first ICU admission (days), median (range) | 2.00 (1.00–5.00) | 2.50 (1.00–9.00) | 0.061 |
| Length of hospital admission (days), median (range) | 22.50 (17.00–34.25) | 26.50 (14.75–41.25) | 0.491 |
SD, standard deviation; BMI, body mass index; CKD, chronic kidney disease; NYHA, New York Heart Association; CABG, coronary artery bypass graft surgery; CHD, congenital heart disease; LVEF, left ventricular ejection fraction; SCR, serum creatinine; eGFR, estimated glomerular filtration rate; WBC, white blood cell; AST, aspartate aminotransferase; ALT, alanine aminotransferase; ICU, intensive care unit.
Main causes of ICU readmission
| Main causes of readmission | All patients (n=184) | Alive (n=154) | Dead (n=30) |
|---|---|---|---|
| Cardiac dysfunction, n (%) | 84 (45.65) | 72 (46.75) | 12 (40.00) |
| Respiratory disorder, n (%) | 51 (27.72) | 49 (31.82) | 2 (6.67) |
| Neurological problems, n (%) | 22 (11.96) | 17 (11.04) | 5 (16.67) |
| Acute renal failure, n (%) | 13 (7.07) | 6 (3.90) | 7 (23.33) |
| Infection, n (%) | 6 (3.26) | 4 (2.60) | 2 (6.67) |
| Cardiac tamponade/bleeding, n (%) | 8 (4.35) | 6 (3.90) | 2 (6.67) |
ICU, intensive care unit.
Multivariable regression analysis for the effect of creatinine and eGFR on survival
| Variable | Incidence, n (%) | Crude model | Multivariable-adjusted model 1 | Multivariable-adjusted model 2 | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| OR (95% CI) | P value | P for Trend | OR (95% CI) | P value | P for Trend | OR (95% CI) | P value | P for Trend | ||||
| Creatinine, per 10 mmol/L | ||||||||||||
| Creatinine | – | 1.12 (1.08–1.17) | <0.001 | – | 1.10 (1.05–1.15) | <0.001 | – | 1.14 (1.07–1.25) | 0.001 | – | ||
| Tertiles | ||||||||||||
| T1 | 2 (6.67) | 1.00 | – | <0.001 | 1.00 | – | 0.003 | 1.00 | – | 0.010 | ||
| T2 | 5 (16.67) | 2.50 (0.47–13.42) | 0.285 | 1.87 (0.32–10.82) | 0.486 | 3.03 (0.28–32.53) | 0.360 | |||||
| T3 | 23 (76.67) | 16.39 (3.66–73.47) | <0.001 | 7.74 (1.61–37.14) | 0.110 | 11.65 (1.26–107.89) | 0.031 | |||||
| ∆Creatinine, per 10 mmol/L | ||||||||||||
| ∆Creatinine | – | 1.14 (1.09, 1.20) | <0.001 | – | 1.11 (1.05–1.17) | <0.001 | – | 1.12 (1.04–1.21) | 0.002 | – | ||
| Tertiles | ||||||||||||
| T1 | 2 (6.67) | 1.00 | – | <0.001 | 1.00 | – | 0.003 | 1.00 | – | 0.007 | ||
| T2 | 5 (16.67) | 2.63 (0.49–14.13) | 0.259 | 1.88 (0.32–11.06) | 0.488 | 5.85 (0.48–70.78) | 0.165 | |||||
| T3 | 23 (76.67) | 17.40 (3.88–78.01) | <0.001 | 7.81 (1.62–37.60) | 0.010 | 15.05 (1.58–143.76) | 0.019 | |||||
| GFR, mL/min | ||||||||||||
| GFR | – | 0.96 (0.94–0.98) | <0.001 | – | 0.97 (0.95, 0.99) | 0.001 | – | 0.95 (0.93–0.98) | 0.001 | – | ||
| Tertiles | ||||||||||||
| T1 | 22 (73.33) | 1.00 | – | <0.001 | 1.00 | 0.004 | 1.00 | 0.005 | ||||
| T2 | 6 (20.00) | 0.19 (0.07–0.52) | 0.001 | 0.33 (0.11–1.01) | 0.053 | 0.22 (0.05–0.92) | 0.038 | |||||
| T3 | 2 (6.67) | 0.06 (0.01–0.27) | 0.001 | 0.13 (0.03–0.62) | 0.010 | 0.05 (0.05–0.55) | 0.014 | |||||
| ∆GFR, mL/min | ||||||||||||
| ∆GFR | – | 0.96 (0.95–0.98) | <0.001 | – | 0.98 (0.96–0.99) | 0.005 | – | 0.97 (0.95–0.99) | 0.005 | – | ||
| Tertiles | ||||||||||||
| T1 | 21 (70.00) | 1.00 | – | <0.001 | 1.00 | – | 0.003 | 1.00 | – | 0.003 | ||
| T2 | 7 (23.33) | 0.25 (0.10–0.64) | 0.004 | 0.42 (0.14–1.28) | 0.127 | 0.53 (0.14–1.96) | 0.339 | |||||
| T3 | 2 (6.67) | 0.06 (0.01–0.29) | <0.001 | 0.10 (0.02–0.52) | 0.006 | 0.02 (0.00–0.41) | 0.012 | |||||
Model 1: adjusted for lactic acid and infection; Model 2: adjusted for age, sex, BMI, NYHA functional classification, aortic surgery, Euro score, APACHE II, AST, ALT, lactic acid, and infection. eGFR, estimated glomerular filtration rate; OR, odds ratio; CI, confidence interval; GFR, glomerular filtration rate; BMI, body mass index; NYHA, New York Heart Association; APACHE II, Acute Physiology and Chronic Health Evaluation II; AST, aspartate aminotransferase; ALT, alanine aminotransferase.
Figure 1Relationship between renal function indicators and log odds ratio (OR) of death after controlling for potential confounding variables (multivariable OR, 95% confidence intervals, and P value are shown). SCR, serum creatinine; eGFR, estimated glomerular filtration rate.